Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 10,781 - 10,800 results of 11,025 for search '(( via ((mean decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (larger decrease)) ))', query time: 0.73s Refine Results
  1. 10781

    Image_1_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  2. 10782

    Image_5_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  3. 10783

    Table_1_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.DOCX by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  4. 10784

    Table_4_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.DOCX by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  5. 10785

    Image_6_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  6. 10786

    Image_2_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  7. 10787

    Image_8_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  8. 10788

    Image_3_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  9. 10789

    Image_9_Characterization of Non-hormone Expressing Endocrine Cells in Fetal and Infant Human Pancreas.jpg by Abu Saleh Md Moin (6189512)

    Published 2019
    “…</p><p>Objective: To establish the replicative frequency and transcriptional identity of CPHN cells, extending our observation on CPHN cell frequency to a larger cohort of fetal and infant pancreas.</p><p>Design, Setting, and Participants: 8 fetal, 19 infant autopsy pancreata were evaluated for CPHN cell frequency; 12 fetal, 24 infant/child pancreata were evaluated for CPHN replication and identity.…”
  10. 10790

    Influence of the bulk viscosity on the convergence and extension of GB. by Mahamar Dicko (3862870)

    Published 2017
    “…While the posterior-wards flow at the GB posterior end is similar, the lateral flow is strongly affected with a much larger ventral-wards convergent flow along DV when the bulk viscosity is reduced to 10 (whereas no qualitative change is seen between 10<sup>3</sup> and 10<sup>2</sup>). …”
  11. 10791

    Image_1_Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats.tiff by Yan-Ting Shiu (9157814)

    Published 2021
    “…Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). …”
  12. 10792

    Image_2_Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats.tiff by Yan-Ting Shiu (9157814)

    Published 2021
    “…Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). …”
  13. 10793

    Data_Sheet_1_Asthma prevalence based on the Baidu index and China's Health Statistical Yearbook from 2011 to 2020 in China.xlsx by Yahui Li (315104)

    Published 2023
    “…Although China has made early efforts in asthma epidemiology and prevention, there is still a lack of unified and comprehensive epidemiological research within the country. …”
  14. 10794

    Image_3_Natural Vascular Scaffolding Treatment Promotes Outward Remodeling During Arteriovenous Fistula Development in Rats.tiff by Yan-Ting Shiu (9157814)

    Published 2021
    “…Natural Vascular Scaffolding (NVS) Therapy is a new technology that interlinks collagen and elastin via photoactivation of a locally delivered small molecule (4-amino-1,8-naphtalamide). …”
  15. 10795

    DataSheet_6_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  16. 10796

    DataSheet_7_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  17. 10797

    DataSheet_1_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  18. 10798

    DataSheet_10_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  19. 10799

    DataSheet_5_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”
  20. 10800

    DataSheet_2_Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.pdf by Cristina Calviño (17004837)

    Published 2023
    “…Finally, the production of edited CAR-T cells at a larger scale allowed the generation and selection of enough HLA-I<sup>KO</sup>/TCR<sup>KO</sup> CAR-T cells that would be compatible with clinical applications. …”